Because DPPIV inhibitors have been used for treating diabetes and because insulin growth factor receptor (IGFR) signaling is important for EC oncogenesis, we speculated that DPPIV affects the IGFR pathway. The gene discussed is DPP4; the disease is diabetes mellitus.